← SynDRA
RASEGLURANT
SynDRA canonical compound SYN0038204 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | GRM5 |
|---|
| Mechanism of action | glutamate receptor negative allosteric modulator |
|---|
All known targets
Mechanisms of action (all sources)
- GRM5 MODULATOR
- Metabotropic glutamate receptor 5 modulator
- glutamate receptor negative allosteric modulator
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- SLC6A2
- ADGRF1
- NEIL2
- HTR1E
- HTR2A
- HTR2B
- HTR2C
- HTR3A
- HTR5A
- HTR6
- HTR7
- MBD4
- MPG
- MUTYH
- NEIL1
- NTHL1
- ADRA1A
- OGG1
- OPRD1
- OPRK1
- OPRM1
- S1PR1
- SIGMAR1
- SLC6A3
- SMUG1
- TDG
- TMEM97
- TSPO
- HTR1D
- HTR1B
- HTR1A
- HRH4
- ADRA1B
- ADRA1D
- ADRA2A
- ADRA2B
- ADRA2C
- ADRB1
- ADRB2
- AGTR1
Cross-references
Synonyms
- ADX-10059
- ADX10059
- Adx 10059
- RefChem:553119
- Raseglurant [INN]
- UNII-66UCJ8Z8L1
- 2-[2-(3-Fluorophenyl)ethynyl]-4,6-dimethylpyridin-3-amine
- 2-(2-(3-Fluorophenyl)ethynyl)-4,6-dimethylpyridin-3-amine
- 2-((3-Fluorophenyl)ethynyl)-4,6-dimethylpyridin-3-amine
- 2-[(3-Fluorophenyl)ethynyl]-4,6-dimethylpyridin-3-amine
- RASEGLURANT [WHO-DD]
- orb2665573
- SCHEMBL3874524
- SCHEMBL29377125
- MEDCLNYIYBERKO-UHFFFAOYSA-N
- 2-(3-Fluoro-phenylethynyl)-4,6-dimethyl-pyridin-3-ylamine
- GLXC-20562
- BDBM50232462
- EX-A11409
- HY-14866
- DB-098439
- H40173
- T200035
- (2-(3-fluoro-phenylethynyl)-4,6-dimethyl-pyridin-3-yl)amine
- 3-PYRIDINAMINE, 2-(2-(3-FLUOROPHENYL)ETHYNYL)-4,6-DIMETHYL-
- C15H13FN2
- ラセグルラント
- Raseglurant hydrochloride
- C15H14ClFN2
- ADX 10059 hydrochloride
- GLXC-15646
- DA-60822
- AKOS024458149
- MS-32679
- HB1557
- CS-0028108
- EX-A11409A
- ADX10059 hydrochloride
Look up RASEGLURANT in the interactive SynDRA portal →